The NF-κB and MAPK pathways, through their control of pro-inflammatory cytokine production and NLRP3 inflammasome activation, are recognized as two significant mechanisms in the pathogenesis of depression (Troubat et al., 2021). Here, NLRP3 is linked to major depressive disorder.